Article Information
History
- November 1, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ricardo Ariel Zimerman1,
- Patrícia Aline Gröhs Ferrareze2,
- Flávio Adsuara Cadegiani3,
- Carlos Gustavo Wambier4,
- Daniel do Nascimento Fonseca5,
- Andrea Roberto de Souza5,
- Andy Goren6,
- Liane Nanci Rotta2,
- Zhihua Ren7,†,* and
- Claudia Elizabeth Thompson2,8,†,*
- 1Hospital da Brigada Militar, Porto Alegre, Brazil
- 2Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
- 3Corpometria Institute, Brasília, Brazil
- 4Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, USA
- 5Samel & Oscar Nicolau Hospitals, Manaus, Brazil
- 6Applied Biology, Inc. Irvine, CA, USA
- 7Suzhou Kintor Pharmaceutical, Inc, Suzhou, China
- 8Department of Pharmacosciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
- ↵*Correspondence:
Corresponding Author: Zhihua Ren: zhren{at}kintor.com.cn, Claudia Elizabeth Thompson: cthompson{at}ufcspa.edu.br
Posted November 01, 2021.
Comparative genomics and characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern (VOC) from Amazonas, Brazil
